The excitement for AI-driven growth will continue to push the broader market higher, but these top medical stocks can provide the defensive safety that investors may need with volatility starting to resurface.
The 2025 Q2 earnings cycle continues to roll along, with this week’s reporting docket notably stacked. And concerning the broader AI frenzy, reports from NVIDIA and Palantir will be key in getting a better gauge on the current AI landscape.
What started as a smooth glide higher for the greenback this week ended in a brutal reversal, after a calamitously weak US jobs report tore through the macro landscape like a rogue wave.
As of 1:35 PM CT today, the President has fired the Commissioner of Labor Statistics, within 6 hours of the latest employment release. So what all of feared about the safety of the independence of our economic statistical agencies has come to pass.
Stocks dumped hard on the worse-than-expected Jobs Report, and some earnings clinkers from the Stocks of Olympus. It was just a matter of time with a market this overbought and so badly mispriced to value and risk.
By 2029, one in five Americans will be over 65, and by 2034, seniors will outnumber kids. This “super age” revolution threatens everything from stock markets to Social Security.
